SELLAS Life Sciences Group, Inc. (SLS) Cash Flow Quarterly - Discounting Cash Flows
SLS
SELLAS Life Sciences Group, Inc.
SLS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
2012 (Q2)
06-30
2012 (Q1)
03-31
2011 (Q4)
12-31
2011 (Q3)
09-30
2011 (Q2)
06-30
2011 (Q1)
03-31
2010 (Q4)
12-31
2010 (Q3)
09-30
2010 (Q2)
06-30
2010 (Q1)
03-31
2009 (Q4)
12-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-30
2008 (Q2)
06-30
2008 (Q1)
03-31
2007 (Q4)
12-31
2007 (Q3)
09-30
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
Report Filing: 2025-11-12 2025-11-12 2025-08-12 2025-05-13 2025-03-20 2024-11-13 2024-08-13
1234
Net Income/Starting Line -25.94 -6.79 -6.6 -5.81 -6.74 -7.11 -7.47
1234
Cash From Operating Activities -30.62 -7.07 -7.33 -9.07 -7.15 -7.81 -9.68
1234
Depreciation and Amortization 0 0 0 0 0 0 0
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 1.88 0.503 0.501 0.505 0.373 0.381 0.334
1234
Other Non-Cash Items 0.591 0.147 0.149 0.147 0.148 0.137 -0.921
1234
Changes in Working Capital -7.15 -0.927 -1.38 -3.91 -0.937 -1.22 -1.62
1234
Accounts Receivable 0 0 0 0 0 0 0
1234
Inventory 0 0 0 0 0 0 0
1234
Accounts Payable -2.31 -1.03 -0.441 0.277 -1.12 -1.77 -1.06
1234
Deferred Revenue -4.84 0.104 -0.938 -4.19 0.181 0.552 -0.566
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities 0 0 0 0 0 0 0
1234
Investments in Property Plant and Equipment 0 0 0 0 0 0 0
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities 0 0 0 0 0 0 0
1234
Sales and Maturities of Investments 0 0 0 0 0 0 0
1234
Other Investing Activities 0 0 0 0 0 0 0
1234
Cash From Financing Activities 53.91 26.09 4.23 23.58 0.008 19.69 0.414
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 53.97 26.09 4.23 23.58 0.071 19.49 0.059
1234
Common Stock Repurchased 0 0 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities -0.063 0 0 0 -0.063 0.202 0.355
1234
Effect of Forex Changes on Cash 0 0 0 0 0 0 0
1234
Net Change in Cash 30.43 19.02 -3.1 14.51 -7.14 11.88 -9.27
1234
Cash at Beginning of Period 13.99 25.4 28.5 13.99 21.13 9.25 18.52
1234
Cash at End of Period 44.42 44.42 25.4 28.5 13.99 21.13 9.25
1234
Free Cash Flow -30.62 -7.07 -7.33 -9.07 -7.15 -7.81 -9.68
1234
Operating Cash Flow -30.62 -7.07 -7.33 -9.07 -7.15 -7.81 -9.68
1234
Capital Expenditure 0 0 0 0 0 0 0
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program